RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: asthma
Accession: DOID:2841
browse the term
Definition: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has_symptom recurring periods of wheezing (a whistling sound while breathing), has_symptom chest tightness, has_symptom shortness of breath, has_symptom mucus production and has_symptom coughing. (DO)
Synonyms: exact_synonym: AS1; asthmas; bronchial asthma
narrow_synonym: ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN; adult onset asthma; airway hyperresponsiveness
related_synonym: ASRT1; ASRT2; ASRT3; ASRT4; ASRT5; ASRT6; ASRT7; ASRT8; Asthma-Related Traits, Susceptibility To, 1; Asthma-Related Traits, Susceptibility To, 2; Asthma-Related Traits, Susceptibility To, 3; Asthma-Related Traits, Susceptibility To, 4; Asthma-Related Traits, Susceptibility To, 5; Asthma-Related Traits, Susceptibility To, 6; Asthma-Related Traits, Susceptibility To, 7; Asthma-Related Traits, Susceptibility To, 8; allergic airway inflammation; asthma and allergic rhinitis, susceptibility to; asthma and atopy, susceptibility to; asthma, protection against; asthma, susceptibility to; asthma-traits, susceptibility to asthma, protection against; beta-2-adrenoreceptor agonist, reduced response to; childhood athma, susceptibility to; rhinoconjunctivitis, susceptibility to
primary_id: MESH:D001249
alt_id: MIM:600807 ; MIM:601690 ; MIM:607277 ; MIM:608584 ; MIM:609958 ; MIM:610906 ; MIM:611064 ; MIM:611403 ; MIM:611960 ; MIM:613207
xref: EFO:0000270 ; EFO:0005414 ; EFO:1002011 ; GARD:10246 ; ICD10CM:J45 ; ICD9CM:493 ; MONDO:0004979 ; NCI:C28397
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
ISO
protein:increased expression:blood, lymphocyte
RGD
PMID:19484671
RGD:4890020
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcc1
ATP-binding cassette, sub-family C member 1
IMP
RGD
PMID:18931056
RGD:5128825
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
no_association
ISO
RGD
PMID:16008680 PMID:19771478
RGD:5128831 , RGD:5128835
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:19383228 PMID:19484664
RGD:4140919 , RGD:4140913
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acsl3
acyl-CoA synthetase long-chain family member 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:19221603
RGD:13831295
NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460
G
Ada
adenosine deaminase
susceptibility
ISO
DNA:polymorphisms (human)
RGD
PMID:16754522
RGD:5128848
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Adam33
a disintegrin and metallopeptidase domain 33
susceptibility no_association disease_progression
ISO IEP
DNA:SNPs: :multiple (human) DNA:SNPs:introns,exon:7575G>A, 11188A>T, 12433T>C (human) mRNA:increased expression:bronchus DNA:polymorphism: :p.M764T (human) mRNA:increased expression:lung DNA:SNPs (human)
RGD GAD
PMID:18778489 PMID:15118671 PMID:16893396 PMID:17339047 PMID:17961406 PMID:19635592 PMID:19940503 More...
RGD:4145378 , RGD:1331525 , RGD:4145382 , RGD:4145380 , RGD:4145379 , RGD:4145360 , RGD:4145359
NCBI chr 2:130,892,739...130,905,734
Ensembl chr 2:130,892,511...130,905,734
G
Adam8
a disintegrin and metallopeptidase domain 8
severity
ISO IEP IMP
mRNA:increased expression:bronchus mRNA:increased expression:respiratory tract
RGD
PMID:17339047 PMID:19373511 PMID:20194813
RGD:4145380 , RGD:5128878 , RGD:5128872
NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
G
Adcy2
adenylate cyclase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr13:68,768,162...69,147,719
Ensembl chr13:68,768,162...69,147,660
G
Adcyap1r1
adenylate cyclase activating polypeptide 1 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21059121
NCBI chr 6:55,428,486...55,478,440
Ensembl chr 6:55,428,963...55,478,436
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
susceptibility
ISO IMP
protein:increased expression:respiratory system fluid/secretion DNA:SNPs: :rs1154404, rs28730619 (human)
RGD
PMID:19514054 PMID:19395503 PMID:17543375 PMID:15919956
RGD:5128890 , RGD:5128891 , RGD:5128882 , RGD:5128892
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
G
Adipoq
adiponectin, C1Q and collagen domain containing
IMP
RGD
PMID:19168697
RGD:5686821
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adora1
adenosine A1 receptor
ISO IMP
DNA:SNPs: :1405C>T (human) protein:increased expression:bronchus
RGD
PMID:19019667 PMID:20400685 PMID:17959644
RGD:4890386 , RGD:4145444 , RGD:5129097
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Adora2a
adenosine A2a receptor
ISO IEP IDA IMP
DNA:SNP (human) mRNA:decreased expression:aorta
RGD
PMID:19019667 PMID:18310516 PMID:16339780 PMID:17293374
RGD:4890386 , RGD:4890366 , RGD:4890385 , RGD:4890380
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
Adrb2
adrenergic receptor, beta 2
susceptibility
ISO IMP
DNA:SNP: :p.Q27E (human) DNA:polymorphism: :p.R16G (human) DNA:SNPs:promoter:multiple (human) DNA:SNPs: :p.R16G, p.Q27E (human) DNA:SNP: :-1023A>G (human) ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to
ClinVar RGD
PMID:8383511 PMID:15284533 PMID:16596417 PMID:1655856 PMID:19423772 PMID:18569231 PMID:19800676 PMID:20004781 PMID:20443840 PMID:19029431 PMID:18785519 PMID:19638684 PMID:15118671 More...
RGD:5129113 , RGD:4145107 , RGD:4145096 , RGD:4145061 , RGD:4145105 , RGD:4145108 , RGD:4145092 , RGD:4145094 , RGD:4145081 , RGD:1331525
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Ager
advanced glycosylation end product-specific receptor
treatment onset
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:lung (rat)
CTD RGD
PMID:23304218 PMID:33075463 PMID:21920897 PMID:23304218
RGD:7244279 , RGD:6767554 , RGD:7244279
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agtr1a
angiotensin II receptor, type 1a
IMP ISO
RGD
PMID:17877756 PMID:19080339
RGD:5147452 , RGD:5147457
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Agtr2
angiotensin II receptor, type 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:19080339
RGD:5147457
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9600491 PMID:11506308 PMID:15118671
RGD:1331525
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Alox15
arachidonate 15-lipoxygenase
IEP IMP
protein:increased expression:lung
RGD
PMID:19628725 PMID:18692885
RGD:5509605 , RGD:5509784
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
G
Alox5
arachidonate 5-lipoxygenase
no_association severity treatment
ISO IDA IEP IMP
DNA:polymorphism:promoter (human) DNA:polymorphism:cds:p.E254K (human) DNA:repeat:promoter (human) protein:increased expression:lung mRNA:increased expression:blood, leukocyte CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:20128419 PMID:17394438 PMID:18204779 PMID:16364163 PMID:19033731 PMID:11035107 PMID:8879219 PMID:12911785 PMID:9642160 PMID:10369259 More...
RGD:4890407 , RGD:4890413 , RGD:4890410 , RGD:4890415 , RGD:4890408 , RGD:4890422 , RGD:5147462 , RGD:5147465 , RGD:5147467 , RGD:734557
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
susceptibility no_association
ISO IMP IEP
DNA:SNP: :rs10507391 (human) mRNA:increased expression:blood, leukocyte DNA:repeat:promoter:-169(A)21 (human) DNA:substitution, repeat:promoter:-336G>A, -169(A)19-23 (human) DNA:polymorphisms:intron:IVS2+12C>A, IVS2+105T>C (human) protein:increased expression:lung DNA:polymorphism:promoter (human) DNA:SNPs (human)
RGD
PMID:20067482 PMID:9642160 PMID:10527888 PMID:12911785 PMID:15784112 PMID:8879219 PMID:11035107 PMID:20128419 PMID:18547289 More...
RGD:4890405 , RGD:5147467 , RGD:5147466 , RGD:5147465 , RGD:5147464 , RGD:5147462 , RGD:4890422 , RGD:4890407 , RGD:4890409
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
G
Ambp
alpha 1 microglobulin/bikunin precursor
ISO
protein:increased expression:serum
RGD
PMID:14621078
RGD:6904149
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
G
Ang
angiogenin, ribonuclease, RNase A family, 5
severity
ISO
protein:increased expression:sputum
RGD
PMID:16478840
RGD:6892719
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
G
Anxa1
annexin A1
IMP
RGD
PMID:22092555
RGD:7421657
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Areg
amphiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15696081
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
G
Arg1
arginase, liver
ISO IEP
DNA:SNP: :rs2781667 (human) CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung, mononuclear cell (human) mRNA:increased expression:lung (mouse)
CTD RGD
PMID:19281908 PMID:19800904 PMID:20124949 PMID:12813022 PMID:12813022
RGD:5129205 , RGD:4143187 , RGD:4143187
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arg2
arginase type II
severity susceptibility
ISO IEP
DNA:SNP: :rs3742879, rs17249437 (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (mouse) DNA:SNPs (human)
CTD RGD
PMID:19281908 PMID:20124949 PMID:12813022 PMID:16387594
RGD:5129205 , RGD:4143187 , RGD:5129207
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Bcl2
B cell leukemia/lymphoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18357729
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdkrb2
bradykinin receptor, beta 2
onset
ISO
DNA:polymorphism:exon (human) protein:increased expression:blood, eosinophil
RGD
PMID:11517947 PMID:8856156 PMID:14727005 PMID:19038786
RGD:4890456 , RGD:4891042 , RGD:4890454 , RGD:4891028
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
Bdnf
brain derived neurotrophic factor
susceptibility severity
ISO
protein:decreased expression:blood, eosinophil DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) DNA:polymorphisms: :p.V66M, -270C>T (human) protein:increased expression:plasma DNA:polymorphisms: :p.V66M (rs6265) (human)
RGD
PMID:12752594 PMID:21723144 PMID:17584309 PMID:20874832 PMID:19895626 PMID:11737043 More...
RGD:4891122 , RGD:8655967 , RGD:4891067 , RGD:4891063 , RGD:4891117 , RGD:4891123
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bglap
bone gamma carboxyglutamate protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8429434
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
G
Bmpr1b
bone morphogenetic protein receptor, type 1B
ISO
protein:decreased expression:bronchus
RGD
PMID:18292470
RGD:5129470
NCBI chr 3:141,540,230...141,875,335
Ensembl chr 3:141,542,897...141,875,186
G
Bmpr2
bone morphogenetic protein receptor type 2
ISO
protein:decreased expression:bronchus
RGD
PMID:18292470
RGD:5129470
NCBI chr 1:59,802,721...59,917,240
Ensembl chr 1:59,802,559...59,918,173
G
C3
complement component 3
severity
IMP ISO IEP
protein:increased expression:serum DNA:SNP:intron:rs11569562 (human) DNA:SNP: :4896C>T (human) protein:increased expression:respiratory system fluid/secretion Interaction with IL4RA DNA:SNPs: :multiple (human)
RGD
PMID:11591733 PMID:20589464 PMID:18566738 PMID:15278436 PMID:20802484 PMID:20402389 PMID:20395963 PMID:16355111 More...
RGD:5129517 , RGD:5129519 , RGD:5129501 , RGD:5129512 , RGD:5129681 , RGD:5129537 , RGD:5129538 , RGD:5129505
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C3ar1
complement component 3a receptor 1
severity
ISO IMP IEP
mRNA:increased expression:lung protein:increased expression:lung, leukocyte
RGD
PMID:15278436 PMID:20802484 PMID:20045013 PMID:17544263 PMID:15940127 PMID:17544263 More...
RGD:5129512 , RGD:5129681 , RGD:5129686 , RGD:5129560 , RGD:5129561 , RGD:5129560
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
G
C5ar1
complement component 5a receptor 1
severity
IMP IEP ISO
protein:increased expression:lung, leukocyte protein:increased expression:respiratory tract
RGD
PMID:16511606 PMID:20802484 PMID:17544263 PMID:15940127
RGD:5130166 , RGD:5129681 , RGD:5129560 , RGD:5129561
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
Card11
caspase recruitment domain family, member 11
susceptibility
IMP ISO
ClinVar Annotator: match by term: Asthma
ClinVar RGD
PMID:18323416 PMID:23027925 PMID:23129749 PMID:25352053 PMID:25741868 PMID:26861442 PMID:28492532 PMID:28824638 PMID:29472930 PMID:16751370 More...
RGD:11100037
NCBI chr 5:140,858,109...140,986,398
Ensembl chr 5:140,858,745...140,986,337
G
Carm1
coactivator-associated arginine methyltransferase 1
ISO
mRNA:decreased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919
G
Casp1
caspase 1
ISO
protein:increased expression:serum
RGD
PMID:12396474
RGD:5130192
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Cat
catalase
severity
ISO IDA
DNA:polymorphism:promoter:-21A>T (human) CTD Direct Evidence: marker/mechanism protein:decreased activity DNA:polymorphism:promoter:-262C>T (human) protein:increased expression:erythrocyte
CTD RGD
PMID:18048809 PMID:19373626 PMID:16622028 PMID:18048809 PMID:19475625
RGD:5130753 , RGD:5130867 , RGD:5130856 , RGD:5130751
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl1
C-C motif chemokine ligand 1
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:20455898
RGD:4891420
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
G
Ccl11
C-C motif chemokine ligand 11
treatment susceptibility severity
ISO IEP IMP
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism DNA:polymorphism: :p.A23T (human) mRNA:increased expression:lung
OMIM CTD RGD
PMID:16304252 PMID:22932891 PMID:17074272 PMID:17845580 PMID:20704746 PMID:18250471 PMID:9034156 PMID:17060636 More...
RGD:5130930 , RGD:7248416 , RGD:4145461 , RGD:4145457 , RGD:4145387 , RGD:4145392 , RGD:4145451 , RGD:4891485
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl17
C-C motif chemokine ligand 17
ISO IMP IEP IDA
mRNA:increased expression:lung protein:increased expression:respiratory system fluid/secretion
RGD
PMID:15993846 PMID:11160256 PMID:20074456 PMID:15947487 PMID:20237293
RGD:2306304 , RGD:4145603 , RGD:4145487 , RGD:4145513 , RGD:4145486
NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
G
Ccl19
C-C motif chemokine ligand 19
ISO
protein:increased expression:bronchus submucosa, mast cell
RGD
PMID:16959919
RGD:5130911
NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577
G
Ccl2
C-C motif chemokine ligand 2
severity treatment
ISO IEP IDA
protein:increased expression:serum CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (mouse) DNA:haplotype::-2518A>G (human) protein:increased expression:lung
CTD RGD
PMID:19373627 PMID:19373627 PMID:12055264 PMID:25441643 PMID:23454776 PMID:17964702 PMID:20205697 More...
RGD:4891466 , RGD:11528570 , RGD:11528569 , RGD:8551842 , RGD:2307055 , RGD:4145509
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl20
C-C motif chemokine ligand 20
ISO
protein:increased expression:respiratory system fluid/secretion associated with Allergic Rhinitis;protein:increased expression:serum
RGD
PMID:18422729 PMID:22469443
RGD:7483597 , RGD:7483618
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccl22
C-C motif chemokine ligand 22
IMP ISO IEP
mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion mRNA:increased expression:lung protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10384142 PMID:18684970 PMID:15993846 PMID:18316417
RGD:4891475 , RGD:4145489 , RGD:2306304 , RGD:4891474
NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
G
Ccl24
C-C motif chemokine ligand 24
susceptibility
ISO IMP
DNA:SNPs: :179T>C, 275C>T (human) DNA:SNPs: :304C>A, 1272A>G (human) protein:increased expression:respiratory system fluid/secretion DNA:SNP: :1265A>G (human) protein:increased expression:plasma
RGD
PMID:15207712 PMID:17548626 PMID:18712274 PMID:12952266 PMID:12761043 PMID:17060636 PMID:16304252 More...
RGD:4891495 , RGD:4891484 , RGD:4891483 , RGD:4891496 , RGD:5130932 , RGD:4891485 , RGD:5130930
NCBI chr 5:135,598,789...135,601,977
Ensembl chr 5:135,598,791...135,601,903
G
Ccl26
C-C motif chemokine ligand 26
treatment
ISO IDA
protein:increased expression:plasma DNA:SNPs: :77C>T, 2497T>G (human) DNA:SNPs: :77C>T, 716A>G, 1579G>A (human)
RGD
PMID:16304252 PMID:25399816 PMID:25530546 PMID:15207712 PMID:18712274
RGD:5130930 , RGD:11087575 , RGD:11081163 , RGD:4891495 , RGD:4891483
NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423
G
Ccl27a
C-C motif chemokine ligand 27A
ISO
RGD
PMID:19541356
RGD:5130899
NCBI chr 4:41,769,467...41,774,251
Ensembl chr 4:41,769,467...41,774,247
G
Ccl28
C-C motif chemokine ligand 28
IEP
mRNA:increased expression:lung (mouse)
RGD
PMID:16290206
RGD:4892195
NCBI chr13:120,085,355...120,115,895
Ensembl chr13:120,085,355...120,115,895
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:18774390
RGD:5130915
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccl5
C-C motif chemokine ligand 5
susceptibility
IEP ISO
protein:increased expression:lung, secretion (mouse) CTD Direct Evidence: marker/mechanism protein:increased expression:smooth muscle cell DNA:transition:5' utr:-403G>A (human)
CTD RGD
PMID:8534483 PMID:20092989 PMID:18208670 PMID:20430255
RGD:4891430 , RGD:2307112 , RGD:4891381
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccl7
C-C motif chemokine ligand 7
ISO IEP
RGD
PMID:21388664 PMID:19965981
RGD:5130983 , RGD:5130979
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
Ccr1
C-C motif chemokine receptor 1
severity
IEP IMP
mRNA:increased expression:lung associated with Respiratory Syncytial Virus Infections
RGD
PMID:15654816 PMID:15593301
RGD:5688158 , RGD:5688159
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Ccr2
C-C motif chemokine receptor 2
susceptibility
ISO IEP
DNA:SNP:cds:p.V64I (human) DNA:haplotype:cds:p.V64I(human) protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:17298432 PMID:23454776 PMID:19917684
RGD:4145110 , RGD:8551842 , RGD:8549811
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr3
C-C motif chemokine receptor 3
IMP ISO IDA
protein:increased expression:respiratory system fluid/secretion, neutrophil DNA:SNP:exon:51T>C (human)
RGD
PMID:18699933 PMID:19017998 PMID:17145927 PMID:16978084 PMID:20220260 PMID:19657453 PMID:20134116 More...
RGD:4145633 , RGD:4145632 , RGD:1601020 , RGD:4145646 , RGD:4145638 , RGD:4145623 , RGD:4145618
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Ccr4
C-C motif chemokine receptor 4
ISO
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
G
Ccr5
C-C motif chemokine receptor 5
no_association
IMP ISO IEP
DNA:polymorphism, frameshift mutation: :-59029G>A, p.S185_T195del (rs333) (human) mRNA:increased expression:lung (mouse) protein:decreased expression:blood, lymphocyte (human) DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:16474097 PMID:23454776 PMID:18094012 PMID:15256090 PMID:20220260
RGD:4892093 , RGD:8551842 , RGD:4892088 , RGD:4892108 , RGD:4145638
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Ccr6
C-C motif chemokine receptor 6
IEP
protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:19917684
RGD:8549811
NCBI chr17:8,454,875...8,477,353
Ensembl chr17:8,454,875...8,475,973
G
Ccr7
C-C motif chemokine receptor 7
IEP
protein:increased expression:lung, dendritic cell (mouse)
RGD
PMID:19917684
RGD:8549811
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
G
Ccr8
C-C motif chemokine receptor 8
ISO
mRNA:increased expression:lung
RGD
PMID:15993846
RGD:2306304
NCBI chr 9:119,921,199...119,923,972
Ensembl chr 9:119,921,180...119,923,972
G
Ccr9
C-C motif chemokine receptor 9
ISO
mRNA, protein:increased expression:blood, mature NK T cell
RGD
PMID:16210593
RGD:5130925
NCBI chr 9:123,596,276...123,612,522
Ensembl chr 9:123,507,504...123,613,395
G
Cd14
CD14 antigen
severity no_association susceptibility
ISO
DNA:polymorphism:promoter:c. -260C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:c. -159C>T (human) DNA:SNPs: : protein:increased expression:serum|DNA:polymorphism:promoter:c. -159C>T (human)
CTD RGD
PMID:17607003 PMID:15940135 PMID:15741437 PMID:19096003 PMID:18312481 PMID:16387800 More...
RGD:4144814 , RGD:4144815 , RGD:4144228 , RGD:4144208 , RGD:4144813
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd1d1
CD1d1 antigen
susceptibility
IMP
associated with fasciolopsiasis
RGD
PMID:20304473
RGD:4140417
NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748
G
Cd209a
CD209a antigen
ISO
RGD
PMID:21471959
RGD:5131188
NCBI chr 8:3,793,395...3,798,984
Ensembl chr 8:3,793,397...3,798,984
G
Cd274
CD274 antigen
treatment
IMP
associated with Chlamydia pneumonia
RGD
PMID:26378990
RGD:41412180
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd28
CD28 antigen
ISO
RGD
PMID:21356099
RGD:5131612
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
G
Cd40
CD40 antigen
treatment
ISO IEP
RGD
PMID:19220210 PMID:20205594 PMID:19159017 PMID:20941750
RGD:5132272 , RGD:8547792 , RGD:4144188 , RGD:4892277
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
severity
IMP
RGD
PMID:9502776
RGD:11352238
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cd80
CD80 antigen
IEP
RGD
PMID:21051864 PMID:21440530 PMID:21352203
RGD:5132621 , RGD:5132619 , RGD:5132620
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
Cd86
CD86 antigen
treatment
IEP IMP ISO
protein:increased expression:lung, alveolar macrophage (mouse) protein:increased expression:blood, B cell (human) protein:increased expression:lung, dendritic cell (rat) DNA:snp:exon:p.I179V rs2681417 (human)
RGD
PMID:20941750 PMID:25344652 PMID:9449507 PMID:20668438 PMID:9551945 PMID:17513529 More...
RGD:4892277 , RGD:11354965 , RGD:4892555 , RGD:4892199 , RGD:4892202 , RGD:4892280
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cdh1
cadherin 1
ISO
RGD
PMID:21540309
RGD:5132878
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdhr3
cadherin-related family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24241537
NCBI chr12:33,083,781...33,142,900
Ensembl chr12:33,083,795...33,142,874
G
Cftr
cystic fibrosis transmembrane conductance regulator
susceptibility
ISO
DNA:deletion: :p.F508del(human)
RGD
PMID:20298391
RGD:4140387
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Chat
choline O-acetyltransferase
ISO
Protein:decreased expression:lung epithelium
RGD
PMID:17328924
RGD:5686690
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
G
Chi3l1
chitinase 3 like 1
susceptibility
ISO
human gene in mouse model ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 7 DNA:snp:5' utr:g.-131C>G rs4950928 (human) protein:increased secretion:serum (human)
OMIM ClinVar RGD
PMID:18403759 PMID:19414556 PMID:19568425 PMID:18003958
RGD:4892663 , RGD:4892630 , RGD:4892632
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Chia1
chitinase, acidic 1
no_association
ISO IMP IEP
DNA:snps:5' utr, cds:multiple (human) DNA:snps:multiple (human) mRNA:increased expression:lung, epithelial cell (human) mRNA:increased expression:lung (mouse)
RGD
PMID:16179638 PMID:20226308 PMID:19548841 PMID:15192232 PMID:14734765
RGD:4996473 , RGD:5024922 , RGD:5024921 , RGD:4985150 , RGD:4990463
NCBI chr 3:106,020,698...106,039,434
Ensembl chr 3:106,020,545...106,039,436
G
Chml
choroideremia-like
ISO
RGD
PMID:18343558
RGD:5133238
NCBI chr 1:175,509,803...175,520,198
Ensembl chr 1:175,509,803...175,520,467
G
Chrm1
cholinergic receptor, muscarinic 1, CNS
ISO
RGD
PMID:16931638
RGD:5133416
NCBI chr19:8,641,369...8,660,970
Ensembl chr19:8,641,153...8,660,951
G
Chrm2
cholinergic receptor, muscarinic 2, cardiac
ISO
DNA:SNP: :rs6962027 (human)
RGD
PMID:19308904
RGD:5509586
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
G
Chrm3
cholinergic receptor, muscarinic 3, cardiac
severity
ISO IMP
RGD
PMID:20394512 PMID:18348887
RGD:5133437 , RGD:5133438
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
G
Chuk
conserved helix-loop-helix ubiquitous kinase
IMP
RGD
PMID:21496385
RGD:5133703
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
G
Clca1
chloride channel accessory 1
susceptibility
IMP ISO
DNA:SNPs (human)
RGD
PMID:11296262 PMID:17898169 PMID:15318163
RGD:4145661 , RGD:4145653 , RGD:4145656
NCBI chr 3:144,710,298...144,738,537
Ensembl chr 3:144,709,578...144,738,537
G
Cldn18
claudin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27215490
NCBI chr 9:99,572,849...99,599,320
Ensembl chr 9:99,571,514...99,599,320
G
Cma1
chymase 1, mast cell
severity susceptibility no_association
ISO
protein:increased expression:lung epithelium, mast cell (human) DNA:duplications:3' utr:g.*254-?dupTG, dupGA (human) DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human)
RGD
PMID:20813890 PMID:15924217 PMID:15248847
RGD:5128804 , RGD:1625396 , RGD:1625397
NCBI chr14:56,178,908...56,182,132
Ensembl chr14:56,178,908...56,182,132
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
DNA:SNP: :RS242941 (human) DNA:SNPs: :rs1876828, rs242939, rs242941 (human)
RGD
PMID:19663668 PMID:16113459
RGD:5147485 , RGD:5147488
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:18408560
RGD:5130938
NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:serum
RGD
PMID:21140796
RGD:5131288
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
severity
IEP IMP ISO
protein:increased expression:lung protein:increased expression:sputum
RGD
PMID:20405019 PMID:9717963 PMID:19213775
RGD:5131473 , RGD:10449521 , RGD:5131476
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csf2rb
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
ISO
RGD
PMID:17145927
RGD:1601020
NCBI chr15:78,210,000...78,235,201
Ensembl chr15:78,209,952...78,238,047
G
Csf2rb2
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage)
ISO
RGD
PMID:17145927
RGD:1601020
NCBI chr15:78,166,707...78,189,921
Ensembl chr15:78,166,707...78,189,921
G
Csf3
colony stimulating factor 3 (granulocyte)
IEP ISO
protein:increased expression:lung
RGD
PMID:20405019 PMID:21396376
RGD:5131473 , RGD:5133731
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
severity treatment no_association
ISO IDA IMP IEP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple (human) DNA:SNP: :rs3087243 (human) DNA:polymorphism:promoter:-318C>T (human) DNA:SNPs:promoter, exon:-1147C>T, -318C>T, 49A>G (human) DNA:polymorphisms:promoter, exon:-318C>T 49A>G (human)
CTD RGD
PMID:28807506 PMID:15871446 PMID:11726402 PMID:15316504 PMID:19895365 PMID:18699801 PMID:12956753 PMID:12114354 PMID:17237396 PMID:16926542 PMID:16677453 PMID:16708626 PMID:17469155 More...
RGD:4891529 , RGD:11344922 , RGD:4891519 , RGD:4891526 , RGD:4891510 , RGD:4891521 , RGD:4891522 , RGD:4891514 , RGD:4891528 , RGD:4891517 , RGD:4891516 , RGD:4891527
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Ctnna3
catenin alpha 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19187332
NCBI chr10:63,265,877...64,841,174
Ensembl chr10:63,265,877...64,839,446
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cx3cr1
C-X3-C motif chemokine receptor 1
no_association
IMP ISO
DNA:SNPs: :p.V249I, rs2669849 (human) DNA:polymorphisms: :p.V249I, p.T280M (human)
RGD
PMID:21037587 PMID:17082760 PMID:17505143
RGD:4891882 , RGD:4891895 , RGD:4891904
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
G
Cxcl1
C-X-C motif chemokine ligand 1
severity
ISO
RGD
PMID:20371397
RGD:5134983
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO IMP
protein:decreased expression:plasma
RGD
PMID:17302903 PMID:16602032 PMID:11994485
RGD:5135439 , RGD:5135457 , RGD:5135452
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21150878
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
mRNA:increased expression:lung
RGD
PMID:20045013
RGD:5129686
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
severity
ISO
RGD
PMID:20371397
RGD:5134983
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl5
C-X-C motif chemokine ligand 5
ISO IEP
mRNA:increased expression:bronchus epithelium
RGD
PMID:17234659 PMID:9620668
RGD:5135243 , RGD:5135265
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcl9
C-X-C motif chemokine ligand 9
IMP
RGD
PMID:15210824
RGD:5135447
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr3
C-X-C motif chemokine receptor 3
susceptibility severity
IEP ISO
DNA:SNP:intron:IVS1+234G>A (human) protein:decreased expression:respiratory system fluid/secretion, T cell
RGD
PMID:18094012 PMID:16043121 PMID:16548899 PMID:17641057
RGD:4892088 , RGD:5143934 , RGD:5143932 , RGD:5135484
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
G
Cyba
cytochrome b-245, alpha polypeptide
susceptibility
ISO
DNA:polymorphism: :-930A>G (human) DNA:SNPs: :-930A>G, 242C>T, 640A>G (human)
RGD
PMID:19459419 PMID:18716406
RGD:4311041 , RGD:4772770
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA, protein:increased expression, decreased activity:lung
RGD
PMID:12415424
RGD:4892074
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
DNA:polymorphism: :1934G>A (human)
RGD
PMID:19575027
RGD:5143944
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IEP
mRNA:decreased expression:leukocyte CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28807506 PMID:20514434 PMID:17081494
RGD:4892076 , RGD:4892220
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cysltr1
cysteinyl leukotriene receptor 1
no_association severity
ISO IMP
DNA:SNPs:promoter, exon:multiple (human) DNA:SNPs:promoter:-634C>T, -475A>C, -336A>G (human) DNA:SNP: :927T>C (human) mRNA, protein:increased expression:respiratory system mucosa
RGD
PMID:16771777 PMID:16630147 PMID:16776674 PMID:8087328 PMID:11591188 PMID:17153879 PMID:17689528 PMID:16387808 PMID:16123393 More...
RGD:4889116 , RGD:4784257 , RGD:4782072 , RGD:4888514 , RGD:4848936 , RGD:4781742 , RGD:4781449 , RGD:4843543 , RGD:4847129
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
DNA:polymorphism: :601A>G (human) DNA:polymorphism: :-1220A>C (human)
RGD
PMID:15475736 PMID:15454733
RGD:5144002 , RGD:5144003
NCBI chr14:73,263,043...73,286,554
Ensembl chr14:73,263,043...73,286,554
G
Dcn
decorin
ISO
RGD
PMID:16387756
RGD:2311423
NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
G
Defb1
defensin beta 1
susceptibility
ISO
DNA:SNP: :-1816 T>C (human) DNA:SNPs:5' utr:g.-52G>A, g.-44C>G, g.-20G>A (human)
RGD
PMID:15696078 PMID:16435024
RGD:4892263 , RGD:4892254
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
G
Dnah5
dynein, axonemal, heavy chain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr15:28,155,000...28,472,191
Ensembl chr15:28,203,898...28,472,198
G
Dnmt1
DNA methyltransferase 1
IEP ISO
DNA,mRNA:hypermethylation,decreased expression:promoter,respiratory tract: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23423710 PMID:23196709
RGD:9588646
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dpp10
dipeptidylpeptidase 10
ISO
DNA:SNPs (human) DNA:SNP:exon (human) protein:increased expression:bronchus DNA:SNP: :rs10208402 (human)
RGD GAD
PMID:21103062 PMID:15118671 PMID:14566338 PMID:17967935 PMID:19672052
RGD:4889866 , RGD:1331525 , RGD:4892276 , RGD:4892278 , RGD:4892275
NCBI chr 1:123,259,871...124,773,774
Ensembl chr 1:123,249,200...124,773,776
G
Ear1
eosinophil-associated, ribonuclease A family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8874658 PMID:12153692 PMID:12587966
NCBI chr14:44,056,222...44,057,096
Ensembl chr14:44,056,222...44,112,974
G
Ebi3
Epstein-Barr virus induced gene 3
IMP
RGD
PMID:21255010
RGD:5128488
NCBI chr17:56,259,623...56,264,022
Ensembl chr17:56,259,640...56,264,022
G
Edn1
endothelin 1
ISO
DNA:transition:intron:g.4124T>C (human) CTD Direct Evidence: marker/mechanism Severe Persistent Allergic Asthma; protein:increased secretion:lung (human)
CTD RGD
PMID:16981460 PMID:11668616 PMID:20588001
RGD:4144869 , RGD:4144895
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Ednra
endothelin receptor type A
IMP
RGD
PMID:18632188 PMID:17448648
RGD:4892288 , RGD:4892322
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
G
Ednrb
endothelin receptor type B
IMP ISO
DNA:polymorphism (human) mRNA:increased expression:bronchus, smooth muscle cell
RGD
PMID:18632188 PMID:17470272 PMID:15245576
RGD:4892288 , RGD:4892321 , RGD:4892324
NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838
G
Egfr
epidermal growth factor receptor
severity
IMP ISO IEP
protein:increased expression:bronchial epithelium (human) protein:increased expression:lung epithelium (mouse) protein:increased expression:lung epithelium (rat)
RGD
PMID:21224214 PMID:12580917 PMID:21072743 PMID:19954006
RGD:5131633 , RGD:5131468 , RGD:5131642 , RGD:5131870
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egr1
early growth response 1
IMP ISO
mRNA:increased expression:bronchoalveolar lavage cell (human) DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:11254538 PMID:18774390 PMID:18507785
RGD:5131985 , RGD:5130915 , RGD:5131993
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Elp1
elongator complex protein 1
no_association
ISO
RGD
PMID:11281413 PMID:12774215
RGD:5129157 , RGD:5129158
NCBI chr 4:56,746,547...56,802,565
Ensembl chr 4:56,749,680...56,802,331
G
Ephx1
epoxide hydrolase 1, microsomal
susceptibility
ISO
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human)
RGD
PMID:17711870
RGD:4889407
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Epx
eosinophil peroxidase
severity disease_progression
ISO
protein:increased activity:sputum,nasal,pharyngeal mucosa
RGD
PMID:26645423 PMID:12199967 PMID:20813885
RGD:11574908 , RGD:13506892 , RGD:13506891
NCBI chr11:87,754,824...87,766,362
Ensembl chr11:87,754,826...87,766,362
G
Esr2
estrogen receptor 2 (beta)
ISO
mRNA:decreased expression:lung (rat)
RGD
PMID:18375789
RGD:8694127
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
F2
coagulation factor II
ISO
protein:increased expression:plasma associated with Rhinosinusitis, associated with Nasal Polyps;protein:increased expression:nasal mucus
RGD
PMID:21658190 PMID:21711961
RGD:5147753 , RGD:5147783
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:19864598
RGD:4892589
NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
G
F7
coagulation factor VII
treatment
ISO
RGD
PMID:24523826
RGD:11040539
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Fas
Fas cell surface death receptor
ISO
mRNA:increased expression:eosinophil
RGD
PMID:16337971
RGD:1600350
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fcer1a
Fc receptor, IgE, high affinity I, alpha polypeptide
severity
ISO
Asthma symptoms persistent despite steroids in humans Fatal asthma subjects
RGD
PMID:20937062 PMID:21388666
RGD:5128717 , RGD:5128711
NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
G
Fcgr2b
Fc receptor, IgG, low affinity IIb
IMP
RGD
PMID:20179765
RGD:11344929
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
G
Fcgr4
Fc receptor, IgG, low affinity IV
susceptibility
ISO
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
Fga
fibrinogen alpha chain
treatment
ISO
RGD
PMID:24523826
RGD:11040539
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fkbp5
FK506 binding protein 5
ISO
ClinVar Annotator: match by term: Asthma
ClinVar
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Foxp3
forkhead box P3
treatment
ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27965764 PMID:29317916 PMID:28944907 PMID:27633092
RGD:38549365 , RGD:38548920
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gata3
GATA binding protein 3
ISO
RGD
PMID:9949310 PMID:18186587
RGD:5128802 , RGD:5128803
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
G
Gc
vitamin D binding protein
IMP ISO
protein, mRNA:increased expression:bronchoalveolar lavage fluid:
RGD
PMID:21169467 PMID:21169467
RGD:5509920 , RGD:5509920
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gsta1
glutathione S-transferase, alpha 1 (Ya)
susceptibility
ISO
DNA:polymorphism:promoter: -69C>T (human)
RGD
PMID:20374258
RGD:5490988
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
G
Gstm1
glutathione S-transferase, mu 1
resistance susceptibility
ISO
DNA:deletion: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16870661 PMID:18988661 PMID:17651144 PMID:21051083 PMID:11075422
RGD:4142509 , RGD:5490962 , RGD:4140921
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstm3
glutathione S-transferase, mu 3
ISO
DNA:polymorphism
RGD
PMID:11470996 PMID:17550934
RGD:5135039 , RGD:5135038
NCBI chr 3:107,871,019...107,876,484
Ensembl chr 3:107,871,012...107,876,599
G
Gstm5
glutathione S-transferase, mu 5
ISO
DNA:polymorphism
RGD
PMID:11470996 PMID:17550934
RGD:5135038 RGD:5135039
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
G
Gsto2
glutathione S-transferase omega 2
susceptibility
ISO
DNA:polymorphism:exon:p. N142D (human)
RGD
PMID:20374258
RGD:5490988
NCBI chr19:47,853,879...47,874,747
Ensembl chr19:47,853,973...47,874,763
G
Gstp1
glutathione S-transferase, pi 1
severity susceptibility disease_progression no_association
ISO IAGP
DNA:polymorphism:exon:p.I105V (rs1695) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:exons:p.I105V (rs1695), A114V (rs1138272) (human) DNA:SNPs:intron,exon:(rs749174), (rs1138272)(human) DNA:SNPs: :p.I105V, p.A114V (human) DNA:polymorphism:exon:p.I105V (human) DNA:SNP: :p.A114V (human)
CTD RGD
PMID:11994713 PMID:16870661 PMID:18988661 PMID:24117884 PMID:29411558 PMID:10806136 PMID:15693909 PMID:20210814 PMID:20858151 PMID:18057098 PMID:16176403 PMID:18709160 PMID:18787219 More...
RGD:4142526 , RGD:5490999 , RGD:5490991 , RGD:5490985 , RGD:4140951 , RGD:4142519 , RGD:4140947 , RGD:4140946
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:15300848 PMID:21051083 PMID:11075422
RGD:4142539 , RGD:5490962 , RGD:4140921
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
ISO
DNA:polymorphisms (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism (human)
CTD RGD
PMID:10792356 PMID:12890388 PMID:10051703 PMID:11802952 PMID:19052351
RGD:5147799 , RGD:1331670 , RGD:5147831 , RGD:5147617
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility disease_progression no_association
ISO
Alternaria sensitive asthma DNA:polymorphisms: : CTD Direct Evidence: marker/mechanism DNA:polymorphisms (human)
CTD RGD
PMID:10792356 PMID:20298583 PMID:20159242 PMID:20214848 PMID:23331206 PMID:11802952 PMID:12890388 PMID:19052351 More...
RGD:4144113 , RGD:13506913 , RGD:4144181 , RGD:13506906 , RGD:5147831 , RGD:5147799 , RGD:5147617
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Ea
histocompatibility 2, class II antigen E alpha
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:20159242
RGD:13506913
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility no_association severity
ISO
DNA:polymorphisms: : CTD Direct Evidence: marker/mechanism DNA:polymorphism (human)
CTD RGD
PMID:16792590 PMID:19528258 PMID:20159242 PMID:23331206 PMID:10051703 PMID:19439981 PMID:20486920 PMID:20214848 More...
RGD:4144196 , RGD:13506913 , RGD:13506906 , RGD:1331670 , RGD:5147663 , RGD:5147607 , RGD:4144181
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-M2
histocompatibility 2, M region locus 2
susceptibility
ISO
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-M3
histocompatibility 2, M region locus 3
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15611928
RGD:5144118
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
G
H2-Pa
histocompatibility 2, P region alpha locus
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:21814517
RGD:13506911
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:20628202
RGD:5128851
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Havcr2
hepatitis A virus cellular receptor 2
IMP
RGD
PMID:17517968
RGD:5135525
NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082
G
Hc
hemolytic complement
severity
IEP ISO IAGP
mRNA:decreased expression:lung
RGD
PMID:10973279 PMID:15278436 PMID:20143644 PMID:11591795 PMID:20802484
RGD:5130158 , RGD:5129512 , RGD:5129706 , RGD:1600651 , RGD:5129681
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hdac2
histone deacetylase 2
ISO
mRNA:decreased expression:macrophage:
RGD
PMID:20538962
RGD:9590321
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdc
histidine decarboxylase
ISO
associated with Rhinitis;DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:20608921
RGD:5128884
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment
IEP
RGD
PMID:18160846
RGD:10402541
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
ISO
RGD
PMID:20084838
RGD:5508450
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
severity
IDA ISO
CTD Direct Evidence: marker/mechanism mRNA;protein:increased expression:Leukocytes, Mononuclear
CTD RGD
PMID:18048809 PMID:20596599 PMID:16196283
RGD:4145403 , RGD:4145408
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hnmt
histamine N-methyltransferase
no_association susceptibility
ISO
ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:10752634 PMID:10803682 PMID:16205835 PMID:17651147 PMID:25741868 PMID:15693910 PMID:21040557 PMID:17651147 PMID:10803682 PMID:16205835 More...
RGD:5128888 , RGD:5128883 , RGD:5128885 , RGD:5128881 , RGD:5128887
NCBI chr 2:23,892,923...23,939,756
Ensembl chr 2:23,892,922...23,939,406
G
Hp
haptoglobin
ISO
RGD
PMID:21471098 PMID:21169467
RGD:5144151 , RGD:5509920
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11932298
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25322896
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Icam1
intercellular adhesion molecule 1
ISO IEP
protein:increased expression:lung, serum (rat) CTD Direct Evidence: marker/mechanism mRNA:increased expression:aorta (mouse) protein:increased secretion:lung (human)
CTD RGD
PMID:17014439 PMID:25003170 PMID:20953388 PMID:20400685 PMID:20205697
RGD:4145331 , RGD:4145444 , RGD:4145509
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifng
interferon gamma
treatment resistance
IDA IMP ISO
protein:increased expression:sputum
RGD GAD
PMID:19542437 PMID:12396623 PMID:15118671 PMID:20953328 PMID:20817868
RGD:5128479 , RGD:10755706 , RGD:1331525 , RGD:4145525 , RGD:4145651
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ifngr1
interferon gamma receptor 1
IAGP ISO
DNA: SNP: Leu467Pro
RGD
PMID:21737883 PMID:12851715
RGD:6480255 , RGD:6480431
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Ifnl2
interferon lambda 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22295096
NCBI chr 7:28,208,209...28,209,957
Ensembl chr 7:28,208,261...28,209,880
G
Ikzf3
IKAROS family zinc finger 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25256354
NCBI chr11:98,355,436...98,437,157
Ensembl chr11:98,355,728...98,436,857
G
Il10
interleukin 10
treatment susceptibility
ISO IMP IEP
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :-627C>A (human) protein:decreased expression:plasma
CTD RGD
PMID:29317916 PMID:20560982 PMID:21998459 PMID:20237464 PMID:20644177 PMID:12938145 PMID:20121766 PMID:20230687 More...
RGD:5131623 , RGD:11046261 , RGD:4140471 , RGD:4140459 , RGD:4143221 , RGD:4140451 , RGD:4140421
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12a
interleukin 12a
IMP
RGD
PMID:17056578 PMID:17548618
RGD:4438438 , RGD:4373570
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
G
Il12b
interleukin 12b
severity susceptibility
ISO
DNA:polymorphisms:introns: ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphisms:promoter, 3'utr: DNA:polymorphism:promoter
ClinVar RGD
PMID:15322986 PMID:15322986 PMID:16210052 PMID:12241719
RGD:1600043 , RGD:4145438 , RGD:4145428
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il13
interleukin 13
susceptibility severity no_association
IMP ISO IDA IEP
ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism associated with Dermatitis, Atopic;DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human) DNA:polymorphism: :-1512A>C, -1112C>T, 2044G>A (human) mRNA, protein:increased expression:esophagus, Bronchoalveolar Lavage Fluid protein:increased expression:serum DNA:polymorphism:cds:p.R130Q (human) DNA:polymorphisms:promoters,exon4: rs1881457, rs1800925, rs20541 (human) DNA:polymorphism: :p. R110Q (human) DNA:SNP: :c. -646A>G (human) protein:increased expression:sputum DNA:polymorphism: :c. 1923C>T (human) DNA:polymorphism:promoter:c. -1055C>T (human) DNA:polymorphisms: :rs20541, rs1295685(human) DNA:polymorphism:3'utr:c.4738G>A (human) DNA:polymorphism: :c.-1055C>T (human) DNA:polymorphism: :c. 2044G>A (human)
ClinVar OMIM CTD RGD
PMID:10699178 PMID:11588017 PMID:11709756 PMID:12847555 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 PMID:15879126 PMID:22867017 PMID:16120094 PMID:23317483 PMID:17006604 PMID:12604708 PMID:12091879 PMID:20819635 PMID:16393274 PMID:18222984 PMID:11758895 PMID:11678850 PMID:19796199 PMID:18258919 PMID:15315330 PMID:17303794 PMID:18328894 PMID:19575932 PMID:16024972 PMID:20484924 PMID:11588017 PMID:20198887 PMID:18341619 More...
RGD:4206706 , RGD:8549509 , RGD:4892639 , RGD:2301686 , RGD:4145664 , RGD:4145453 , RGD:4145508 , RGD:2307110 , RGD:4763153 , RGD:4763761 , RGD:4145601 , RGD:4145639 , RGD:4321828 , RGD:4146241 , RGD:4145777 , RGD:4145775 , RGD:4220633 , RGD:4145534 , RGD:4765128 , RGD:4145593 , RGD:4145776
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il13ra1
interleukin 13 receptor, alpha 1
no_association
IDA ISO IMP IEP
DNA:polymorphism: :1398A>G (human) DNA:polymorphisms:promoter, 3' utr:-281T>G, 1365A>G (human) DNA:polymorphism: :1050C>T (human) mRNA:increased expression:bronchus
RGD
PMID:11714828 PMID:17006604 PMID:17392323 PMID:10686479 PMID:18480254 PMID:20383033 More...
RGD:4892654 , RGD:4892639 , RGD:4892650 , RGD:4892655 , RGD:4892647 , RGD:4892646
NCBI chr X:35,375,761...35,434,915
Ensembl chr X:35,375,763...35,434,912
G
Il13ra2
interleukin 13 receptor, alpha 2
IMP ISO IEP
protein:increased expression:serum mRNA:increased expression:bronchus
RGD
PMID:17885690 PMID:21462799 PMID:20383033
RGD:4892649 , RGD:8549521 , RGD:4892646
NCBI chr X:146,166,474...146,214,982
Ensembl chr X:146,166,472...146,212,188
G
Il15
interleukin 15
no_association
IMP ISO
DNA:SNPs: :multiple (human)
RGD
PMID:15843549 PMID:16629787 PMID:11160248 PMID:15131572 PMID:19133918
RGD:5000757 , RGD:4984421 , RGD:4990462 , RGD:5000758 , RGD:5000760
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Il16
interleukin 16
no_association severity
IMP ISO
DNA:SNP:promoter:-295T>C (human) protein:increased expression:serum associated with Rhinitis;protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10585533 PMID:15784111 PMID:16387589 PMID:12872394 PMID:16734115
RGD:5024937 , RGD:5024935 , RGD:5024934 , RGD:5024930 , RGD:5024928
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Il17a
interleukin 17A
susceptibility
ISO IMP
mRNA,protein:increased expression:Leukocytes, Mononuclear, lung, serum protein:increased expression:sputum protein:increased expression:alveolar macrophage DNA:SNP:promoter:rs2275913 (human)
RGD
PMID:18060619 PMID:20351038 PMID:15730730 PMID:18941201 PMID:20437253
RGD:4839043 , RGD:4888527 , RGD:4889114 , RGD:4889152 , RGD:4889139
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il17rb
interleukin 17 receptor B
IMP
associated with Picornaviridae Infections
RGD
PMID:25273095
RGD:39128256
NCBI chr14:29,718,125...29,730,853
Ensembl chr14:29,718,092...29,730,853
G
Il18
interleukin 18
severity susceptibility disease_progression
ISO IMP
DNA:SNPs:Promoter:c. -607C>A (rs1946518), -137G/C (rs187238) (human) DNA:SNP:promoter:c.and -137G>C (rs187238)(human) protein:increased expression:serum DNA:SNP:promoter: c.-380C>G (rs5744247)(human) DNA:polymorphism: :c. -105A>C (human)
RGD
PMID:17767553 PMID:20497957 PMID:16433859 PMID:18826499 PMID:11174201 PMID:20497957 PMID:19745201 PMID:18200581 More...
RGD:4889585 , RGD:4889898 , RGD:4889923 , RGD:4889908 , RGD:4889863 , RGD:4889898 , RGD:4889900 , RGD:4889910
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18r1
interleukin 18 receptor 1
ISO IEP
DNA:SNP: :rs3771166 (human) DNA:SNPs: :multiple (human)
RGD
PMID:19910030 PMID:20860503 PMID:18382474 PMID:11972614 PMID:18774397
RGD:5024945 , RGD:5024942 , RGD:5024947 , RGD:5024948 , RGD:5024946
NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
G
Il19
interleukin 19
IEP
mRNA, protein:increased expression:lung, serum
RGD
PMID:15557163
RGD:5037236
NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
G
Il1a
interleukin 1 alpha
ISO
DNA:polymorphisms: :
RGD
PMID:18763028
RGD:4142802
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
susceptibility
IDA ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:neutrophil DNA:polymorphism: :-511C>T (human)
CTD RGD
PMID:9176529 PMID:19684087 PMID:19842845 PMID:18926055
RGD:4142836 , RGD:4142830 , RGD:4142864
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
susceptibility severity
IEP ISO IMP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNP: :rs1420101 (human) DNA:SNPs:intron:rs1420089, rs1861245,rs1946131 (human) DNA:SNP: :rs10197862 (human) DNA:SNP: :rs1041973 (human)
CTD RGD
PMID:19198610 PMID:21150878 PMID:21804549 PMID:24241537 PMID:27472835 PMID:17623648 PMID:17407196 PMID:19179489 PMID:19198610 PMID:19852851 PMID:21150878 PMID:21281963 PMID:11463601 More...
RGD:5144235 , RGD:5144245 , RGD:5144244 , RGD:5144243 , RGD:5144242 , RGD:5144240 , RGD:5144239 , RGD:5144237
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il1rn
interleukin 1 receptor antagonist
susceptibility severity
ISO
DNA:SNP: :rs2234678 (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple (human) DNA:SNPs: :rs447713, rs3087271 (human) protein:increased expression:plasma DNA, protein:repeat, decreased expression (human) DNA:polymorphism:intron (human)
CTD RGD
PMID:9176529 PMID:17107994 PMID:15020290 PMID:16409203 PMID:16724092 PMID:10843772 PMID:11027520 PMID:18926055 PMID:18763028 More...
RGD:4143208 , RGD:4143216 , RGD:4143163 , RGD:4143209 , RGD:4143225 , RGD:4143224 , RGD:4142864 , RGD:4142802
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
susceptibility
ISO
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:20926789 PMID:16333313
RGD:4889118 , RGD:8663473
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il21
interleukin 21
ISO
DNA:SNP:exon:5250C>T (human)
RGD
PMID:18802358
RGD:5147396
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il22
interleukin 22
treatment severity
IMP ISO
mRNA:increased expression:blood, mononuclear cell protein:increased expression:serum
RGD
PMID:21789181 PMID:21998459 PMID:21535180 PMID:21297073
RGD:5147401 , RGD:11046261 , RGD:5147409 , RGD:5147403
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
G
Il22b
interleukin 22B
severity
ISO
protein:increased expression:serum mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21297073 PMID:21535180
RGD:5147403 RGD:5147409
NCBI chr10:118,125,534...118,130,943
Ensembl chr10:118,125,534...118,130,943
G
Il23r
interleukin 23 receptor
IMP
RGD
PMID:19935773
RGD:5037240
NCBI chr 6:67,399,906...67,468,838
Ensembl chr 6:67,399,916...67,468,839
G
Il25
interleukin 25
IEP
mRNA, protein:increased expression:lung
RGD
PMID:25273095
RGD:39128256
NCBI chr14:55,170,152...55,173,294
Ensembl chr14:55,170,152...55,173,294
G
Il27
interleukin 27
treatment susceptibility
IDA IMP ISO
protein:increased expression:sputum DNA:SNP: :g.-964A>G (human)
RGD
PMID:17878337 PMID:26595888 PMID:20817868 PMID:17318299 PMID:19542437
RGD:5128491 , RGD:11076728 , RGD:4145651 , RGD:5128485 , RGD:5128479
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il27ra
interleukin 27 receptor, alpha
IMP
RGD
PMID:16081811
RGD:5128496
NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
G
Il2ra
interleukin 2 receptor, alpha chain
IMP
RGD
PMID:21377197 PMID:20525707
RGD:5147437 , RGD:5147445
NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
G
Il2rb
interleukin 2 receptor, beta chain
ISO IMP
DNA:SNP: :rs2284033 (human)
RGD
PMID:20860503 PMID:18641329
RGD:5024942 , RGD:5147447
NCBI chr15:78,363,456...78,396,569
Ensembl chr15:78,363,456...78,379,471
G
Il3
interleukin 3
susceptibility
ISO
DNA:SNP: :rs40401(human) DNA:polymorphism:cds:+79T>C(S27P)(human)
RGD
PMID:24684517 PMID:15372320
RGD:13506914 , RGD:13506916
NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
G
Il33
interleukin 33
treatment severity
ISO IMP
CTD Direct Evidence: marker/mechanism associated with viral pneumonia; associated with fungal infectious disease
CTD RGD
PMID:19198610 PMID:21804549 PMID:24241537 PMID:27472835 PMID:29067999 PMID:28947081 PMID:25746970 More...
RGD:39939002 , RGD:39938968
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il4
interleukin 4
treatment no_association
IMP ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increase expression:leukocyte, serum protein:increased expression:lung DNA:SNP: :589C>T (human) DNA:polymorphism (human) mRNA:increased expression:lung, spleen protein:increased expression:respiratory system fluid/secretion
CTD RGD
PMID:18357729 PMID:21375458 PMID:24946644 PMID:24450480 PMID:18211752 PMID:20524005 PMID:21103062 PMID:21364926 PMID:21354484 More...
RGD:5128557 , RGD:10402799 , RGD:10402791 , RGD:2317290 , RGD:5128560 , RGD:4889866 , RGD:5128500 , RGD:5128502
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il4ra
interleukin 4 receptor, alpha
susceptibility severity disease_progression
ISO IAGP IMP
DNA:polymorphism:cds:p.Q551R (human) OMIM:600807 DNA:polymorphism:cds:p.I50V (human) DNA:polymorphism::-1902G/A (human) DNA:SNPs: :multiple DNA:SNPs:cds:p. I75V, Q576R (human) protein:increased secretion:plasma|DNA:polymorphism:promoter:c.-3223C>T (human) DNA:SNPs:cds:p.E375A, Q551R (human) DNA:polymorphism:cds:p.Q576R (human) DNA:polymorphism:cds:p. S478P (human) DNA:mutation:cds:p.Q576R (mouse)
MouseDO RGD
PMID:17586032 PMID:18425216 PMID:20868478 PMID:17823973 PMID:11398072 PMID:12133990 PMID:15479272 PMID:17170387 PMID:12940513 PMID:11709756 PMID:20953944 PMID:20605987 PMID:19770271 PMID:16917945 More...
RGD:4890348 , RGD:4890346 , RGD:4890387 , RGD:4890347 , RGD:4890406 , RGD:4890404 , RGD:4890351 , RGD:4890349 , RGD:4890402 , RGD:4890024 , RGD:5128514 , RGD:5128553 , RGD:4890003 , RGD:4890352
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
Il5
interleukin 5
treatment disease_progression
IEP ISO IMP
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism protein:increased expression:lungs, respiratory system fluid/secretion protein: increased levels: sputum DNA:polymorphism:promoter:-703C>T (human)
CTD RGD
PMID:7540862 PMID:23266719 PMID:15626484 PMID:25008888 PMID:11159041 PMID:22085848 PMID:22186238 PMID:15502111 PMID:9182686 PMID:17074272 PMID:9493449 PMID:18629290 PMID:19947994 More...
RGD:4890947 , RGD:11354973 , RGD:5687189 , RGD:5687144 , RGD:5687140 , RGD:4890948 , RGD:4890963 , RGD:4145461 , RGD:4890962 , RGD:4890940 , RGD:4890938
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il5ra
interleukin 5 receptor, alpha
IMP ISO
DNA:SNP: :c.25091G>A (human) DNA:SNPs (human)
RGD
PMID:10848907 PMID:20592918 PMID:17276963 PMID:10224351 PMID:16217591 PMID:20513521 More...
RGD:5128627 , RGD:5128614 , RGD:5128617 , RGD:5128623 , RGD:5128626 , RGD:5128625
NCBI chr 6:106,687,336...106,725,998
Ensembl chr 6:106,687,318...106,725,998
G
Il6
interleukin 6
IDA ISO
CTD Direct Evidence: marker/mechanism associated with Hypersensitivity;protein:increased expression:sputum protein:increased expression:lung
CTD RGD
PMID:29902480 PMID:21115736 PMID:20840469 PMID:20816188 PMID:20658762
RGD:5128630 , RGD:4143265 , RGD:4143266 , RGD:4143271
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6ra
interleukin 6 receptor, alpha
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29902480 PMID:17496315 PMID:21115736
RGD:5128662 , RGD:5128630
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
G
Il9
interleukin 9
ISO IMP IEP
protein:increased expression:respiratory system fluid/secretion protein:increased expression:sputum, macrophage, cytoplasm
RGD
PMID:21356110 PMID:17446528 PMID:15531759 PMID:15303135 PMID:12153980
RGD:5128707 , RGD:5128686 , RGD:5128690 , RGD:5128691 , RGD:5128700
NCBI chr13:56,627,090...56,630,070
Ensembl chr13:56,627,090...56,630,059
G
Il9r
interleukin 9 receptor
ISO
RGD
PMID:10629460
RGD:5128704
NCBI chr11:32,137,544...32,155,283
Ensembl chr11:32,137,541...32,150,279
G
Irak3
interleukin-1 receptor-associated kinase 3
susceptibility
ISO
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 5
ClinVar OMIM
PMID:17503328
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Irf1
interferon regulatory factor 1
no_association susceptibility
ISO
DNA:polymorphisms:promoter, cds:-300G>T, 4396A>G, 6355G>A (human) DNA:repeat:intron (human) protein:increased expression:respiratory tract epithelium
RGD
PMID:11069564 PMID:16961714 PMID:10225979
RGD:5128726 , RGD:5128724 , RGD:5128723
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
G
Irf3
interferon regulatory factor 3
IMP
RGD
PMID:20673978
RGD:5128793
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
G
Itgb3
integrin beta 3
ISO
DNA:SNPs: :
RGD
PMID:17556058
RGD:5037230
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Itgb6
integrin beta 6
IAGP
OMIM:600807
MouseDO
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
G
Itpr1
inositol 1,4,5-trisphosphate receptor 1
ISO
RGD
PMID:21777465
RGD:5147661
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
G
Kdr
kinase insert domain protein receptor
IMP ISO
associated with Rhinitis,Allergic,Seasonal;protein:increased expression:nasal cavity of mucosa:
RGD
PMID:20921519 PMID:17651148
RGD:5684385 , RGD:8551771
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Kif3a
kinesin family member 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr11:53,456,531...53,495,075
Ensembl chr11:53,458,206...53,492,794
G
Krt19
keratin 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15478392
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
G
Lep
leptin
ISO
protein:increased expression:plasma
RGD
PMID:19705789
RGD:5128781
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lgals3
lectin, galactose binding, soluble 3
treatment
ISO
RGD
PMID:16424226
RGD:9685213
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lta
lymphotoxin A
susceptibility no_association
ISO
DNA:polymorphisms:promoter DNA:polymorphism:intron
RGD
PMID:15969671 PMID:18947013 PMID:17536219 PMID:12530118
RGD:4143373 , RGD:4143370 , RGD:4143371 , RGD:4143254
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Lta4h
leukotriene A4 hydrolase
ISO
mRNA:increased expression:lung, cerebral cortex (rat)
RGD
PMID:15715933
RGD:2316607
NCBI chr10:93,289,258...93,320,758
Ensembl chr10:93,289,273...93,320,737
G
Mbl2
mannose-binding lectin (protein C) 2
susceptibility
ISO
associated with Bronchiolitis;DNA:polymorphism:exon: DNA:SNP:cds:p.G54D(human)
RGD
PMID:22512728 PMID:22674410
RGD:8693709 , RGD:12910828
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mefv
Mediterranean fever
susceptibility
ISO
DNA:mutations:exons
RGD
PMID:18219832
RGD:5129186
NCBI chr16:3,524,838...3,536,073
Ensembl chr16:3,525,082...3,535,961
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
severity
ISO IMP
protein:increased expression:bronchoalveolar lavage fluid DNA:SNP:promoter:rs755622(human) DNA:repeats:promoter
RGD
PMID:9637721 PMID:19317738 PMID:17373669 PMID:16186482 PMID:16455830
RGD:4891043 , RGD:4891059 , RGD:4891035 , RGD:4891052 , RGD:1641985
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mmp10
matrix metallopeptidase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16926187
NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24469321
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism protein:increased expression:lung DNA:SNP: : rs2664538(human) mRNA, protein:increased expression:lung
CTD RGD
PMID:11742282 PMID:15131573 PMID:21439806 PMID:19361849 PMID:20181264 PMID:16191269 PMID:19940022 More...
RGD:5129204 , RGD:5129687 , RGD:5130859 , RGD:2325953 , RGD:5129522
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
susceptibility
ISO
DNA:polymorphism: :−463G > A (human) protein:increased expression:serum
RGD
PMID:19544176 PMID:10731862
RGD:5130989 , RGD:5130994
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Ms4a2
membrane-spanning 4-domains, subfamily A, member 2
susceptibility
ISO
DNA:SNPs:multiple:, rs573790, rs2583476, rs569108 DNA:SNPs: : rs556917, rs502581, rs502419 (human) DNA:SNP: : -109C>T (human) Atopy and bronchial hyperresponsiveness, OMIM:147050
RGD
PMID:19218813 PMID:21320344 PMID:19862939 PMID:8817330
RGD:5131151 , RGD:5131149 , RGD:5131092 , RGD:1599903
NCBI chr19:11,592,881...11,601,154
Ensembl chr19:11,592,887...11,601,083
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:transition:cds:g.677C>T (human)
RGD
PMID:20456312
RGD:4891145
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Muc1
mucin 1, transmembrane
ISO
protein:increased expression:serum
RGD
PMID:11802251
RGD:5131281
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Muc2
mucin 2
ISO IEP
associated with hypersensitivity
RGD
PMID:11062147 PMID:14594655
RGD:5131178 , RGD:7349354
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
treatment
ISO IDA IEP
protein:increased expression:lung mRNA, protein:increased expression:lung mRNA,protein:increased expression:lung
RGD
PMID:17698377 PMID:21549818 PMID:21780541 PMID:14594655 PMID:17590487
RGD:5131204 , RGD:7364729 , RGD:7349407 , RGD:7349354 , RGD:2324962
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Muc5b
mucin 5, subtype B, tracheobronchial
ISO IEP
protein:altered expression:sputum
RGD
PMID:11802783 PMID:11587997
RGD:5131252 , RGD:7364763
NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
G
Myb
myeloblastosis oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
G
Myd88
myeloid differentiation primary response gene 88
ameliorates
IMP
RGD
PMID:26882889
RGD:11531666
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
G
Mylk
myosin, light polypeptide kinase
ISO
RGD
PMID:17472811
RGD:4891492
NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
susceptibility
ISO
DNA:polymorphisms: : Asthma, Aspirin-Induced; DNA:polymorphism: :
RGD
PMID:16924569 PMID:20602614
RGD:5131606 , RGD:5131600
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
severity
ISO
mRNA:increased expression:bronchoalveolar lavage cell, peripheral blood mononuclear cell (human)
RGD
PMID:21514635
RGD:6893376
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Ngf
nerve growth factor
severity
ISO IEP
protein:increased expression:blood, eosinophil protein:increased expression:lung, serum
RGD
PMID:12752594 PMID:17164945 PMID:11737043 PMID:17497413
RGD:4891122 , RGD:4891108 , RGD:4891123 , RGD:4891068
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
IMP
RGD
PMID:16603479 PMID:12540484
RGD:5144070 , RGD:5144072
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Nod1
nucleotide-binding oligomerization domain containing 1
susceptibility
ISO
DNA:SNP: :rs2075817 (human) DNA:insertion:cds:
RGD
PMID:16918516 PMID:15718249
RGD:5131519 , RGD:5131518
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO IDA
DNA:polymorphisms:intron, exon/3'UTR (rs1077861, rs3135500) (human)
RGD
PMID:16008671 PMID:21051079
RGD:5131477 , RGD:5508757
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Nos1
nitric oxide synthase 1, neuronal
susceptibility
ISO
DNA:repeats:exon DNA:repeats:intron DNA:repeats: :
RGD
PMID:10833424 PMID:14767694 PMID:10673365 PMID:20609134
RGD:5132860 , RGD:5132615 , RGD:5132869 , RGD:5132863
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
severity disease_progression no_association
IMP ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:lung (rat) DNA:repeats:promoter protein:increased expression:lung, bronchoalveolar lavage fluid associated with Rhinitis, Allergic, Seasonal; protein:increased expression:nasal mucosa DNA:repeats:promoter, introns (human) DNA:SNP:exon:p.S608L (human) mRNA:increased expression:monocyte DNA:repeat:promoter
CTD RGD
PMID:19800904 PMID:20841959 PMID:21847581 PMID:18714530 PMID:17161822 PMID:18254476 PMID:17189532 PMID:17177683 PMID:20842520 PMID:16540403 PMID:16703578 More...
RGD:4891480 , RGD:5509073 , RGD:4891508 , RGD:4891927 , RGD:4891910 , RGD:4891924 , RGD:4891925 , RGD:4891419 , RGD:4891957 , RGD:4891953
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
susceptibility
ISO
DNA:snps, repeat, haplotype:promoter, introns, exons:multiple (human) DNA:polymorphisms:promoter:c. -786C>T, -691C>T (human) DNA:repeats:intron
RGD
PMID:18486767 PMID:16837812 PMID:16081038
RGD:4892053 , RGD:4892058 , RGD:4892062
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Npsr1
neuropeptide S receptor 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 2
OMIM CTD ClinVar RGD
PMID:15073379 PMID:15710598 PMID:15764725 PMID:16926187 PMID:15073379 PMID:18285428 PMID:17702965 More...
RGD:4891921 , RGD:4891922 , RGD:4891923
NCBI chr 9:24,009,212...24,229,151
Ensembl chr 9:24,009,292...24,227,694
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9731035
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
susceptibility
ISO
DNA:SNP:exon:c. 609C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNP:exon:c.609C>T (human)
CTD RGD
PMID:20049212 PMID:19027876 PMID:19591959
RGD:5135006 , RGD:5135005
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment susceptibility severity
ISO
DNA:polymorphism:intron protein:increased expression, decreased activity:leukocyte, mononuclear
RGD
PMID:18396779 PMID:28297812 PMID:20727335 PMID:21113676 PMID:18799869 PMID:15295049 More...
RGD:4892328 , RGD:408364991 , RGD:7174728 , RGD:4892568 , RGD:4892594 , RGD:4892609
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Ntf3
neurotrophin 3
IEP ISO
protein:increased expression:lung, serum
RGD
PMID:17497413 PMID:11737043
RGD:4891068 , RGD:4891123
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntf5
neurotrophin 5
IEP
protein:increased expression:lung, serum
RGD
PMID:17497413
RGD:4891068
NCBI chr 7:45,063,119...45,066,603
Ensembl chr 7:45,063,119...45,066,603
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
IMP ISO
mRNA:increased expression:lung:
RGD
PMID:20934630 PMID:16708804
RGD:5684766 , RGD:5684772
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ormdl3
ORM1-like 3 (S. cerevisiae)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21150878 PMID:25256354
NCBI chr11:98,472,120...98,478,071
Ensembl chr11:98,472,082...98,478,194
G
P2ry12
purinergic receptor P2Y, G-protein coupled 12
ISO IMP
RGD
PMID:22010907 PMID:19822647
RGD:6480532 , RGD:6480533
NCBI chr 3:59,123,692...59,170,408
Ensembl chr 3:59,123,693...59,170,292
G
Parp1
poly (ADP-ribose) polymerase family, member 1
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism protein:increased activation:lung, blood, mononuclear cell
CTD RGD
PMID:18261157 PMID:12594058 PMID:26205779 PMID:26205779
RGD:5683910 , RGD:11073727 , RGD:11073727
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pdcd1
programmed cell death 1
treatment
IMP
associated with Chlamydia pneumonia
RGD
PMID:26378990
RGD:41412180
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pde4b
phosphodiesterase 4B, cAMP specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pde4d
phosphodiesterase 4D, cAMP specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19426955 PMID:21611147
NCBI chr13:108,790,711...110,092,503
Ensembl chr13:108,586,482...110,089,995
G
Pdgfb
platelet derived growth factor, B polypeptide
IEP ISO
protein: increased expression
RGD
PMID:21216974 PMID:21216974
RGD:6483071 , RGD:6483071
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pgf
placental growth factor
IMP
RGD
PMID:22268141
RGD:6483605
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IMP
RGD
PMID:18754810
RGD:6482695
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pin1
peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1
IMP
RGD
PMID:18188456
RGD:8693422
NCBI chr 9:20,563,335...20,575,008
Ensembl chr 9:20,563,391...20,577,880
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
ISO
RGD
PMID:15557087
RGD:1642462
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10733466 PMID:10733466
RGD:1581025
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21912604 PMID:18519237
RGD:4892037
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Ppp2ca
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22205926
NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
G
Prf1
perforin 1 (pore forming protein)
IMP ISO
RGD
PMID:22250087 PMID:21426642
RGD:6482815 , RGD:6482818
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
G
Prg2
proteoglycan 2, bone marrow
severity disease_progression no_association
ISO IMP
mRNA:increased expression:eosinophil: associated with cough;protein:increased expression:sputum: associated with viral infection;mRNA:increased expression:sputum:
RGD
PMID:16982448 PMID:22022864 PMID:24450586 PMID:11067904
RGD:13506941 , RGD:13506944 , RGD:13506943 , RGD:13506942
NCBI chr 2:84,810,805...84,813,977
Ensembl chr 2:84,810,805...84,813,976
G
Prmt1
protein arginine N-methyltransferase 1
ISO
mRNA:increased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr 7:44,626,179...44,635,844
Ensembl chr 7:44,625,413...44,635,992
G
Prmt2
protein arginine N-methyltransferase 2
ISO
mRNA:increased expression:lung, spleen
RGD
PMID:20423833
RGD:9491823
NCBI chr10:76,043,060...76,073,699
Ensembl chr10:76,043,056...76,073,699
G
Prmt3
protein arginine N-methyltransferase 3
ISO
mRNA:increased expression:lung
RGD
PMID:20423833
RGD:9491823
NCBI chr 7:49,428,067...49,508,016
Ensembl chr 7:49,428,094...49,508,013
G
Prmt5
protein arginine N-methyltransferase 5
ISO
mRNA:increased expression:lung, spleen
RGD
PMID:20423833
RGD:9491823
NCBI chr14:54,744,639...54,754,927
Ensembl chr14:54,744,644...54,754,982
G
Proc
protein C
treatment
ISO
RGD
PMID:26381519
RGD:11099992
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Prol1
proline rich, lacrimal 1
ISO
ClinVar Annotator: match by term: Asthma, protection against CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:11378823 PMID:16759176 PMID:28492532
NCBI chr 5:88,465,171...88,476,676
Ensembl chr 5:88,465,171...88,476,673
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17982072
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptgdr
prostaglandin D receptor
susceptibility
ISO
OMIM
NCBI chr14:45,088,692...45,096,832
Ensembl chr14:45,088,692...45,096,832
G
Ptgdr2
prostaglandin D2 receptor 2
ISO IMP
Aspirin exacerbated asthma CTD Direct Evidence: therapeutic
CTD RGD
PMID:27103662 PMID:19796209 PMID:19392992 PMID:18757520
RGD:5135020 , RGD:5135019 , RGD:5135018
NCBI chr19:10,901,883...10,919,875
Ensembl chr19:10,914,524...10,919,875
G
Ptger3
prostaglandin E receptor 3 (subtype EP3)
treatment
ISO
RGD
PMID:23221044
RGD:10043366
NCBI chr 3:157,272,459...157,350,392
Ensembl chr 3:157,272,529...157,351,525
G
Ptgs2
prostaglandin-endoperoxide synthase 2
susceptibility severity
ISO IEP IMP
mRNA:increased expression:lung DNA:SNP: :8473T>C (human) mRNA, protein:increased expression:lung: DNA:SNP: :rs689465 (human)
RGD
PMID:19862936 PMID:19878559 PMID:15316498 PMID:17573729 PMID:18097056 PMID:18489027 PMID:19342146 More...
RGD:5135515 , RGD:5135514 , RGD:5143931 , RGD:5143923 , RGD:5135534 , RGD:5135526 , RGD:5135522
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rad50
RAD50 double strand break repair protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24241537
NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146
G
Rhoa
ras homolog family member A
ISO
RGD
PMID:18391481
RGD:2298885
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Runx1
runt related transcription factor 1
ISO
DNA:SNPs: :multiple
RGD
PMID:21803869
RGD:6482835
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
G
Runx3
runt related transcription factor 3
IAGP
OMIM:600807
MouseDO
NCBI chr 4:134,847,956...134,905,301
Ensembl chr 4:134,847,963...134,905,301
G
Scgb1a1
secretoglobin, family 1A, member 1
susceptibility
ISO
mRNA,protein:decreased expression:bronchial alveolar lavage fluid, lung: ClinVar Annotator: match by term: Asthma, susceptibility to associated with allergic rhinitis; DNA:SNP:exon:38G>A (human) protein:decreased expression:serum
ClinVar RGD
PMID:9550363 PMID:9643286 PMID:12100044 PMID:12921604 PMID:21255142 PMID:15467329 More...
RGD:5144052 , RGD:5144226 , RGD:5144148
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
G
Scgb3a2
secretoglobin, family 3A, member 2
susceptibility severity no_association
ISO IEP IDA
DNA:SNP:promoter:-112G>A (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Asthma, susceptibility to mRNA,protein:decreased expression:;lung protein:increased expression:sputum
CTD OMIM ClinVar RGD
PMID:11813133 PMID:11813133 PMID:15531759 PMID:16456148 PMID:17218572 PMID:18089940 PMID:18201431 More...
RGD:5144229 , RGD:5128690 , RGD:5144233 , RGD:5144232 , RGD:5144231 , RGD:5144230
NCBI chr18:43,897,346...43,900,464
Ensembl chr18:43,897,354...43,900,464
G
Sell
selectin, lymphocyte
IMP
RGD
PMID:21437035 PMID:21515793
RGD:5685685 , RGD:5685696
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
severity susceptibility no_association
ISO
protein:increased expression:plasma DNA:polymorphism:promoter:rs1799768 (human) protein:increased activity, increased expression:plasma, lung
RGD
PMID:19703828 PMID:19063817 PMID:19604112 PMID:18594148
RGD:4144831 , RGD:4144832 , RGD:4144833 , RGD:4144836
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Sftpa1
surfactant associated protein A1
ISO IEP
protein:decreased expression:lung, Clara cell, pneumocyte mRNA, protein:increased expression:lung
RGD
PMID:15816355 PMID:16629790 PMID:18926058 PMID:18802356
RGD:4143398 , RGD:4143462 , RGD:4143289 , RGD:4143516
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
G
Sftpb
surfactant associated protein B
ISO IEP
protein:increased expression:lung mRNA, protein:decreased expression:lung protein:decreased expression:lung, Clara cell
RGD
PMID:16629790 PMID:11472974 PMID:15816355 PMID:18926058
RGD:4143462 , RGD:4143465 , RGD:4143398 , RGD:4143289
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Sftpc
surfactant associated protein C
susceptibility
ISO IEP
DNA:polymorphism: :p.A53T (human) protein:increased expression:lung mRNA, protein:decreased expression:lung
RGD
PMID:19910179 PMID:16629790 PMID:11472974
RGD:4144063 , RGD:4143462 , RGD:4143465
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
G
Sftpd
surfactant associated protein D
ISO IEP
mRNA, protein:increased expression:lung associated with Bronchitis;protein:increased expression:lung
RGD
PMID:18802356 PMID:11472974 PMID:18266831 PMID:16839409 PMID:16629790
RGD:4143516 , RGD:4143465 , RGD:4143517 , RGD:4143508 , RGD:4143462
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
G
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
IAGP
RGD
PMID:12847242
RGD:5684966
NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221
G
Slc18a3
solute carrier family 18 (vesicular monoamine), member 3
ISO
RGD
PMID:17328924
RGD:5686690
NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
ISO
RGD
PMID:17328924
RGD:5686690
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc5a7
solute carrier family 5 (choline transporter), member 7
ISO
mRNA:decreased expression:lung
RGD
PMID:17328924
RGD:5686690
NCBI chr17:54,580,618...54,606,071
Ensembl chr17:54,580,618...54,606,062
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
susceptibility
ISO
DNA:repeat:intron (human)
RGD
PMID:19806585
RGD:4889460
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22867017
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
RGD
PMID:15743779
RGD:1581231
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sprr2b
small proline-rich protein 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912604
NCBI chr 3:92,224,012...92,225,448
Ensembl chr 3:92,223,927...92,225,392
G
Stat4
signal transducer and activator of transcription 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28807506 PMID:18211752
RGD:2317290
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Stat6
signal transducer and activator of transcription 6
treatment
ISO
RGD
PMID:19087723 PMID:16083555
RGD:7244151 , RGD:7244153
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
G
Tac1
tachykinin 1
ISO
protein:increased expression:lung
RGD
PMID:11031342
RGD:5147836
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tacr1
tachykinin receptor 1
ISO
protein:increased expression:lung mRNA:increased expression:lung mRNA,protein:increased expression:lung
RGD
PMID:17392578 PMID:8240667 PMID:16409782
RGD:2304339 , RGD:5147645 , RGD:5147475
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tacr2
tachykinin receptor 2
ISO
DNA:SNP:cds:p.G231E (human)
RGD
PMID:20175803 PMID:19880429
RGD:5147640 , RGD:5147641
NCBI chr10:62,088,217...62,101,769
Ensembl chr10:62,088,217...62,101,769
G
Tap1
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:12640628
RGD:5147845
NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199
G
Tbx21
T-box 21
ISO IAGP
CTD Direct Evidence: marker/mechanism OMIM:600807
CTD MouseDO
PMID:15806396
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Tbxa2r
thromboxane A2 receptor
susceptibility severity
ISO
ClinVar Annotator: match by term: Asthma DNA:polymorphism:cds:924T>C(human)
ClinVar RGD
PMID:2955539 PMID:7929844 PMID:8428006 PMID:8613548 PMID:15118671 PMID:12000493 PMID:15805995 More...
RGD:1331525 , RGD:11059535 , RGD:11059534
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tgfb1
transforming growth factor, beta 1
no_association onset
ISO IMP IEP
DNA:polymorphism: :-509C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, exon:multiple (human) mRNA:increased expression:lung protein:increased expression:serum DNA:SNP:cds:915G>C (human) DNA:polymorphisms: :multiple (human) DNA:SNP: :-509C>T (human)
CTD RGD
PMID:16365456 PMID:19138248 PMID:19222424 PMID:19620629 PMID:19096005 PMID:20485865 PMID:19317336 PMID:19046298 PMID:19136038 PMID:18366906 PMID:17673695 PMID:18711258 PMID:19533439 More...
RGD:4145299 , RGD:4145132 , RGD:4145143 , RGD:4145113 , RGD:4145139 , RGD:4145142 , RGD:4145144 , RGD:4145280 , RGD:4145295 , RGD:4143443 , RGD:4145297
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Thbd
thrombomodulin
ISO
RGD
PMID:20709825
RGD:5684984
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Timp3
tissue inhibitor of metalloproteinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16926187
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Tlr1
toll-like receptor 1
susceptibility
ISO
DNA:SNP (human)
RGD
PMID:18547625
RGD:4889528
NCBI chr 5:65,082,023...65,090,945
Ensembl chr 5:65,082,022...65,090,906
G
Tlr2
toll-like receptor 2
susceptibility severity
ISO IEP IMP
DNA:SNP: :596T>C (human) DNA:polymorphism:cds:p.R753Q(human) DNA:SNP: :rs3804100 (human) DNA:SNP: :rs4696480 (human) DNA:SNP: :rs7656411 (human)
RGD
PMID:19096003 PMID:22402138 PMID:19148143 PMID:20685742 PMID:20815312 PMID:18202345 PMID:18787777 More...
RGD:4144228 , RGD:7800732 , RGD:2312679 , RGD:4144171 , RGD:4145352 , RGD:4145343 , RGD:4145334
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr3
toll-like receptor 3
no_association
ISO IMP
Asthma, Virus-Induced; mRNA:increased expression:sputum (human) DNA:snp:cds:p.L412F (human)
RGD
PMID:21129050 PMID:14987294 PMID:21364926 PMID:17434873 PMID:17610940
RGD:5129226 , RGD:5129493 , RGD:5128500 , RGD:5129478 , RGD:5129475
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Tlr4
toll-like receptor 4
susceptibility no_association severity
ISO IDA IMP
DNA:Polymorphism:cds:p.D299G (human) DNA:SNPs: :rs10983755, rs1927914 (human) DNA:SNPs:: protein:decreased expression:leukocytes, mononuclear DNA:polymorphisms:cds:c.896A>G, 1196C>T (human)
RGD
PMID:15356557 PMID:19159017 PMID:20628601 PMID:19330007 PMID:20685742 PMID:19067129 PMID:16266379 More...
RGD:4144817 , RGD:4144188 , RGD:4144176 , RGD:4144141 , RGD:4144171 , RGD:4144190 , RGD:4144198
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr6
toll-like receptor 6
susceptibility
ISO
DNA:SNP (human) DNA:SNP: :p.S249P (human)
RGD
PMID:18547625 PMID:15266299
RGD:4889528 , RGD:4889538
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
G
Tlr9
toll-like receptor 9
no_association susceptibility severity
ISO IMP
DNA:snp:promoter:g.-1237T>C rs5743836 (human) protein:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:21324137 PMID:18312481 PMID:20016192 PMID:20072849
RGD:5130712 , RGD:4144208 , RGD:5129104 , RGD:4889523
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnc
tenascin C
ISO IMP
DNA:SNP:exon:p.L1677I (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple (human) protein:increased expression:bronchus basement membrane
CTD RGD
PMID:16115819 PMID:16115819 PMID:18305139 PMID:17125141 PMID:9310019
RGD:4889569 , RGD:4889589 , RGD:4889565 , RGD:4889572
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
G
Tnf
tumor necrosis factor
susceptibility no_association
ISO IMP
DNA:polymorphism:promoter: c. -308A>G (human) ClinVar Annotator: match by term: Asthma, susceptibility to CTD Direct Evidence: marker/mechanism associated with obesity; DNA:polymorphism:promoter DNA:polymorphisms:: rs1799964, rs1799724 (human) DNA:polymorphisms: : associated with nasal polys; protein:increased expression:nose DNA:polymorphism:promoter:c.-863C > A (human)
OMIM ClinVar CTD RGD
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12356572 PMID:12485196 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16456144 PMID:16720636 PMID:16865291 PMID:16909270 PMID:17450233 PMID:18050183 PMID:18713756 PMID:19365401 PMID:20049212 PMID:22760475 PMID:22992668 PMID:18711258 PMID:19196817 PMID:16393274 PMID:18811622 PMID:12530118 PMID:18763028 PMID:20465535 PMID:16728705 More...
RGD:4143443 , RGD:4143238 , RGD:4145508 , RGD:4143240 , RGD:4143254 , RGD:4142802 , RGD:4143369 , RGD:4143372
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
IEP
protein:increased expression:lung (mouse)
RGD
PMID:20484920
RGD:5131201
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnip1
TNFAIP3 interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24453940
NCBI chr11:54,801,613...54,853,766
Ensembl chr11:54,801,611...54,853,743
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
severity
ISO
CTD Direct Evidence: marker/mechanism ovalbumin sensitization
CTD RGD
PMID:19458046 PMID:31969645
RGD:127285811
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
G
Tslp
thymic stromal lymphopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21804549
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
Ucn
urocortin
ISO
associated with Hypersensitivity;mRNA, protein:increased expression:lung
RGD
PMID:16427607
RGD:1642781
NCBI chr 5:31,295,333...31,296,239
Ensembl chr 5:31,295,407...31,296,173
G
Uts2
urotensin 2
ISO
RGD
PMID:17045018
RGD:2306832
NCBI chr 4:151,081,554...151,086,267
Ensembl chr 4:151,081,554...151,086,267
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
no_association
ISO
DNA:SNP: :rs7975232 (human) DNA:SNPs (human) DNA:SNP (human) DNA:SNPs: :multiple (human)
RGD
PMID:19622139 PMID:20124605 PMID:21103062 PMID:15282200
RGD:4889868 , RGD:4889867 , RGD:4889866 , RGD:4889854
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:sputum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11907124 PMID:15201500 PMID:19263519 PMID:19178538
RGD:6892723
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vip
vasoactive intestinal polypeptide
ISO IDA
RGD
PMID:21419198 PMID:16782752
RGD:5685381 , RGD:5685620
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
G
Wdr36
WD repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr18:32,970,241...33,000,008
Ensembl chr18:32,970,278...33,000,647
G
Cxcl15
C-X-C motif chemokine ligand 15
treatment
ISO
RGD
PMID:30059697
RGD:39939057
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Ccl26
C-C motif chemokine ligand 26
treatment
IDA
RGD
PMID:25530546
RGD:11081163
NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423
G
Cysltr1
cysteinyl leukotriene receptor 1
treatment
IMP
RGD
PMID:23933317
RGD:40903070
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
G
Epx
eosinophil peroxidase
ISO
protein:increased expression:urine:
RGD
PMID:11846868
RGD:13506893
NCBI chr11:87,754,824...87,766,362
Ensembl chr11:87,754,826...87,766,362
G
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility
ISO
RGD
PMID:22397267
RGD:13506905
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-M2
histocompatibility 2, M region locus 2
susceptibility
ISO
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-Pa
histocompatibility 2, P region alpha locus
susceptibility
ISO
DNA:polymorphism:
RGD
PMID:28380482
RGD:13506910
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
G
Il25
interleukin 25
treatment
IMP
RGD
PMID:17889290
RGD:40902975
NCBI chr14:55,170,152...55,173,294
Ensembl chr14:55,170,152...55,173,294
G
Trem1
triggering receptor expressed on myeloid cells 1
exacerbates
IEP IDA
RGD
PMID:21592044 PMID:21592044
RGD:126928124 , RGD:126928124
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Cacng6
calcium channel, voltage-dependent, gamma subunit 6
susceptibility
ISO
DNA:SNP,haplotype:rs192808(human)
RGD
PMID:20860846
RGD:13524562
NCBI chr 7:3,472,017...3,484,183
Ensembl chr 7:3,472,711...3,484,183
G
Ccr3
C-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20485159 PMID:20022477
RGD:4145619
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481 PMID:17641958 PMID:20485159
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15970796
RGD:5144000
NCBI chr14:73,263,043...73,286,554
Ensembl chr14:73,263,043...73,286,554
G
Fancc
Fanconi anemia, complementation group C
ISO
DNA:haplotype::rs4647416(human)
RGD
PMID:21670957
RGD:11045795
NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
Il4
interleukin 4
susceptibility
ISO
DNA:SNPs:promoter,5'UTR,intron:multiple
RGD
PMID:20921925
RGD:11528633
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159
NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
G
Ms4a2
membrane-spanning 4-domains, subfamily A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr19:11,592,881...11,601,154
Ensembl chr19:11,592,887...11,601,083
G
Postn
periostin, osteoblast specific factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
G
Ptgdr2
prostaglandin D2 receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr19:10,901,883...10,919,875
Ensembl chr19:10,914,524...10,919,875
G
Ptger2
prostaglandin E receptor 2 (subtype EP2)
ISO
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15496426 PMID:16502481
NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
G
Ptgir
prostaglandin I receptor (IP)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 7:16,640,442...16,644,828
Ensembl chr 7:16,640,415...16,644,830
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:9487340
RGD:5143936
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
ISO
RGD
PMID:21796142
RGD:5147839
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
Tbx21
T-box 21
ISO
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15806396 PMID:16502481
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Tbxa2r
thromboxane A2 receptor
susceptibility
ISO
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15898979
RGD:11059537
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
H2-Ea
histocompatibility 2, class II antigen E alpha
susceptibility
ISO
DNA:SNPs,haplotype:introns:
RGD
PMID:22391069
RGD:13506908
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
Tbx21
T-box 21
ISO
ClinVar Annotator: match by term: Asthma and nasal polyps
ClinVar
PMID:15806396
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Alox15
arachidonate 15-lipoxygenase
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:17959182 PMID:21558275 PMID:25741868 PMID:30643255
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
G
Ltc4s
leukotriene C4 synthase
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:25741868
NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
G
Ptger2
prostaglandin E receptor 2 (subtype EP2)
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
G
Tbx21
T-box 21
susceptibility
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:25741868
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
exacerbates
ISO
associated with respiratory syncytial virus infectious disease;DNA:SNPs:protomer: (rs2233409) (human)
RGD
PMID:23487427
RGD:40902982
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Ngf
nerve growth factor
treatment
ISO
RGD
PMID:30681402
RGD:405100716
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ccl26
C-C motif chemokine ligand 26
severity
ISO
protein:increased expression:sputum (human)
RGD
PMID:25936567
RGD:11531115
NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423
G
Epx
eosinophil peroxidase
treatment
ISO
RGD
PMID:28751233
RGD:13506890
NCBI chr11:87,754,824...87,766,362
Ensembl chr11:87,754,826...87,766,362
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:10984370
RGD:4890423
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:lung, secretion (human)
RGD
PMID:19996575
RGD:4892021
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Tacr1
tachykinin receptor 1
ISO
RGD
PMID:8630576
RGD:5147837
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Acsl3
acyl-CoA synthetase long-chain family member 3
IEP
RGD
PMID:23526225
RGD:13831300
NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Cd86
CD86 antigen
treatment
IMP
RGD
PMID:25344652
RGD:11354965
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Fas
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Il23a
interleukin 23, alpha subunit p19
IMP
RGD
PMID:19935773 PMID:26344076
RGD:5037240 , RGD:11251537
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
G
Ager
advanced glycosylation end product-specific receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33075463
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Cdh17
cadherin 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 4:11,758,157...11,817,905
Ensembl chr 4:11,758,147...11,817,895
G
H2-M2
histocompatibility 2, M region locus 2
susceptibility
ISO
DNA:SNP: :rs1811197(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-Oa
histocompatibility 2, O region alpha locus
treatment
ISO
DNA:SNP: :rs3128935(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208
G
H2-T23
histocompatibility 2, T region locus 23
susceptibility
ISO
DNA:SNP: :rs1573294(human)
RGD
PMID:24709764
RGD:13506912
NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 7:55,699,872...55,884,373
Ensembl chr 7:55,699,944...55,881,548
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Prkca
protein kinase C, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
G
Prkd1
protein kinase D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27504716
NCBI chr12:50,388,009...50,696,075
Ensembl chr12:50,388,014...50,695,881
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Tenm3
teneurin transmembrane protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25918132
NCBI chr 8:48,678,700...51,370,255
Ensembl chr 8:48,680,717...49,296,986
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25721048
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
ClinVar Annotator: match by term: Platelet-activating factor acetylhydrolase deficiency CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:8675689 PMID:9412624 PMID:10194471 PMID:10733466 PMID:16787988 PMID:25741868 PMID:28406212 More...
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
Ifng
interferon gamma
resistance
IDA
RGD
PMID:20817868
RGD:4145651
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:lung
RGD
PMID:9927362
RGD:4143184
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il5
interleukin 5
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10934091
RGD:4890960
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Mpo
myeloperoxidase
ISO
protein:increased expression:serum
RGD
PMID:10731862
RGD:5130994
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all